skip to main content
Idioma:
Refinado por: assunto: Adolescent remover assunto: Leukemias. Malignant Lymphomas. Malignant Reticulosis. Myelofibrosis remover Hematopoietic Stem Cell Transplantation remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia
Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Pre-transplant imatinib-based therapy improves the outcome of allogeneic hematopoietic stem cell transplantation for BCR-ABL-positive acute lymphoblastic leukemia

MIZUTA, S ; MATSUO, K ; MIYAZAKI, Y ; OHTAKE, S ; ATSUTA, Y ; SAKAMAKI, H ; KAWA, K ; MORISHIMA, Y ; OHNISHI, K ; NAOE, T ; OHNO, R ; YAGASAKI, F ; YUJIRI, T ; HATTA, Y ; KIMURA, Y ; UEDA, Y ; KANAMORI, H ; USUI, N ; AKIYAMA, H

Leukemia, 2011-01, Vol.25 (1), p.41-47 [Periódico revisado por pares]

Avenel, NJ: Nature Publishing Group

Texto completo disponível

Citações Citado por
2
Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute lymphoblastic leukemia
Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute lymphoblastic leukemia
Material Type:
Artigo 		Adicionar ao Meu Espaço

Combination of intensive chemotherapy and imatinib can rapidly induce high-quality complete remission for a majority of patients with newly diagnosed BCR-ABL–positive acute lymphoblastic leukemia

Towatari, Masayuki ; Yanada, Masamitsu ; Usui, Noriko ; Takeuchi, Jin ; Sugiura, Isamu ; Takeuchi, Makoto ; Yagasaki, Fumiharu ; Kawai, Yasukazu ; Miyawaki, Shuichi ; Ohtake, Shigeki ; Jinnai, Itsuro ; Matsuo, Keitaro ; Naoe, Tomoki ; Ohno, Ryuzo

Blood, 2004-12, Vol.104 (12), p.3507-3512 [Periódico revisado por pares]

Washington, DC: Elsevier Inc

Texto completo disponível

Citações Citado por
3
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Karyotype at diagnosis is the major prognostic factor predicting relapse-free survival for patients with Philadelphia chromosome-positive acute lymphoblastic leukemia treated with imatinib-combined chemotherapy

Yanada, Masamitsu ; Takeuchi, Jin ; Sugiura, Isamu ; Akiyama, Hideki ; Usui, Noriko ; Yagasaki, Fumiharu ; Nishii, Kazuhiro ; Ueda, Yasunori ; Takeuchi, Makoto ; Miyawaki, Shuichi ; Maruta, Atsuo ; Narimatsu, Hiroto ; Miyazaki, Yasushi ; Ohtake, Shigeki ; Jinnai, Itsuro ; Matsuo, Keitaro ; Naoe, Tomoki ; Ohno, Ryuzo ; Japan Adult Leukemia Study Group

Haematologica (Roma), 2008-02, Vol.93 (2), p.287-290 [Periódico revisado por pares]

Pavia: Haematologica

Texto completo disponível

Citações Citado por

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.